Current understanding of the functional roles of aberrantly expressed microRNAs in esophageal cancer

World J Gastroenterol. 2016 Jan 7;22(1):1-7. doi: 10.3748/wjg.v22.i1.1.

Abstract

The incidence of esophageal cancer is rising, mostly because the increasing incidence of esophageal adenocarcinoma in Western countries. Despite improvements in diagnosis and treatment, the overall 5-year survival rates remain low. MicroRNAs (miRNAs) are small non-coding RNA molecules that regulate the expression of target genes. Recently, disease specific miRNAs have been identified, which act as tumor suppressors or oncogenes. In this review, we will summarize the current knowledge about the function of aberrantly expressed miRNAs in esophageal cancer. We selected 5 miRNAs (miRNA-21, -143, -145, -196a and let-7) based on the available literature, and described their potential role in regulating pathways that are deregulated in esophageal cancer. Finally we will highlight the current achievements of using and targeting miRNAs. Because these miRNAs likely have important regulatory roles in cancer development, they open a therapeutic window for new treatment modalities.

Keywords: Esophageal adenocarcinoma; Esophageal cancer; Esophageal squamous cell carcinoma; MicroRNAs; Target genes.

Publication types

  • Editorial
  • Review

MeSH terms

  • Adenocarcinoma / genetics
  • Adenocarcinoma / metabolism
  • Carcinoma, Squamous Cell / genetics
  • Carcinoma, Squamous Cell / metabolism
  • Esophageal Neoplasms / genetics*
  • Esophageal Neoplasms / metabolism*
  • Esophageal Neoplasms / therapy
  • Gene Expression Regulation, Neoplastic
  • Genes, Tumor Suppressor
  • Humans
  • MicroRNAs / genetics*
  • MicroRNAs / metabolism*
  • Oncogenes
  • RNA, Neoplasm / genetics*
  • RNA, Neoplasm / metabolism*

Substances

  • MicroRNAs
  • RNA, Neoplasm